Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 2:22 pm Purchase | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | Consonance Capital Management LP | 6,058,505 11.000% | 3,169,617 (+109.72%) | Filing History |
| 2021-02-16 2:21 pm Purchase | 2020-12-31 | 13G | Omeros Corporation OMER | Consonance Capital Management LP | 6,058,505 11.000% | 2,862,709 (+89.58%) | Filing History |
| 2021-02-16 2:21 pm Purchase | 2020-12-31 | 13G | Liminal BioSciences Inc. LMNL | Consonance Capital Management LP | 605,851 11.000% | 277,119 (+84.30%) | Filing History |
| 2021-02-16 2:21 pm Sale | 2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Consonance Capital Management LP | 403,900 11.000% | -4,595 (-1.12%) | Filing History |
| 2021-02-16 2:21 pm Sale | 2020-12-31 | 13G | Kadmon Holdings, Inc. KDMN | Consonance Capital Management LP | 6,834,770 9.990% | -8,807,294 (-56.31%) | Filing History |
| 2021-02-16 2:21 pm Purchase | 2020-12-31 | 13G | IVERIC bio, Inc. ISEE | Consonance Capital Management LP | 6,058,505 9.990% | 2,632,140 (+76.82%) | Filing History |
| 2021-02-16 2:21 pm Purchase | 2020-12-31 | 13G | GENMARK DIAGNOSTICS INC GNMK | Consonance Capital Management LP | 6,058,505 9.990% | 6,058,505 (New Position) | Filing History |
| 2021-02-16 2:21 pm Purchase | 2020-12-31 | 13G | GAMIDA CELL LTD GMDAQ | Consonance Capital Management LP | 6,058,505 9.990% | 6,058,505 (New Position) | Filing History |
| 2021-02-16 2:20 pm Purchase | 2020-12-31 | 13G | CONSONANCE-HFW ACQUISITION COR CHFWU | Consonance Capital Management LP | 6,058,505 9.990% | 4,624,505 (+322.49%) | Filing History |
| 2021-02-16 2:20 pm Purchase | 2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Consonance Capital Management LP | 605,851 9.990% | 605,851 (New Position) | Filing History |
| 2021-02-16 2:20 pm Purchase | 2020-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI | Consonance Capital Management LP | 605,851 9.990% | 605,851 (New Position) | Filing History |
| 2021-02-16 2:20 pm Purchase | 2020-12-31 | 13G | CareDx, Inc CDNA | Consonance Capital Management LP | 6,058,505 11.000% | 3,936,529 (+185.51%) | Filing History |
| 2021-02-16 2:20 pm Purchase | 2020-12-31 | 13G | AxoGen, Inc. AXGN | Consonance Capital Management LP | 6,058,505 11.000% | 3,072,119 (+102.87%) | Filing History |
| 2021-02-16 2:19 pm Sale | 2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH | Consonance Capital Management LP | 6,058,505 11.000% | -567,166 (-8.56%) | Filing History |
| 2021-02-16 2:19 pm Sale | 2020-12-31 | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 6,058,505 11.000% | -679,701 (-10.09%) | Filing History |
| 2021-02-16 2:11 pm Sale | 2020-12-31 | 13G | ADMA Biologics, Inc. ADMA | Consonance Capital Management LP | 1,558,290 1.650% | -3,608,671 (-69.84%) | Filing History |
| 2020-12-03 1:40 pm Purchase | 2020-11-23 | 13D | CONSONANCE-HFW ACQUISITION COR CHFWU | Consonance Capital Management LP | 1,434,000 14.900% | 1,434,000 (New Position) | Filing History |
| 2020-11-05 4:55 pm Sale | 2020-10-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Consonance Capital Management LP | 1,252,229 3.990% | -988,550 (-44.12%) | Filing History |